Delivery Order SPE2DE24D0013-SPE2D625F78SR
- Not listed
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract worth $82,060.00 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract award is part of a larger Indefinite Delivery Contract vehicle with the...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract valued at $8,160.00 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, which has no set-aside designation, is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract award is part of a larger...
- The U.S. government has awarded a $3,400.00 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain, is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $17,361.00, has an ultimate completion date of March 19, 2025. Cepheid is a prime contractor and...
- The U.S. government agency the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $12,240.00, has an ultimate completion date of April 10, 2025. Cepheid...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $18,700.00, is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract is part of a larger Indefinite Delivery Contract (IDC) vehicle with...
- This is a $13,600.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions. The contract has no set-aside designation and is part of a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $44,854.40, is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no...
- This is a $27,200.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other conditions. The contract is not designated as a...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $20,400.00 firm fixed-price delivery order contract to the prime contractor, Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, which does not have a set-aside designation, is for the delivery of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F78SRDelivery Order
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $4,420.98 to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract is part of a larger Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17, valued at $1,424,520, and a Blanket Purchase Agreement (BPA) with the VA Veterans Integrated Service Network 2, valued at $3,112,410.10. These IDC and BPA vehicles enable the VA to continuously procure Cepheid's molecular diagnostic solutions. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 2/13/25 |